Breast Cancer Mutations <i>HER2V777L</i> and <i>PIK3CAH1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug ResistanceXiaoqing Cheng, Ron Bose|Cancer Research|2023Cited by 31
Breast cancer mutations HER2 <sup>V777L</sup> and PIK3CA <sup>H1047R</sup> activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistanceXiaoqing Cheng, Ron Bose|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0
Cerebellum metastasis model of HER2-positive breast cancer unveils key role of IL34-induced Arg1+ macrophagesXiaoqing Cheng, Ron Bose|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0